More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...
David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback